Company Filing History:
1 out of 223 
1 out of 238 
Years Active: 2020
Title: The Innovative Contributions of Joris De Wit
Introduction
Joris De Wit, an acclaimed inventor based in Kessel-Lo, Belgium, has made significant strides in the field of neurological and psychiatric disorders. With one patent to his name, his innovative work has the potential to revolutionize approaches to brain health and treatment.
Latest Patents
De Wit's patent, titled "Therapeutic agents for neurological and psychiatric disorders," addresses critical issues within the central nervous system. This invention highlights the discovery that soluble amyloid precursor protein alpha (sAPPα) binds to the GABAR1a receptor, thereby producing an agonistic effect. This discovery allows for a reduction in the frequencies of excitatory and inhibitory postsynaptic currents. The patented compounds can selectively interfere with the association of sAPPα with Sushi domain 1 of GABAR1a, offering new avenues for treating various neurological and psychiatric conditions. Additionally, the invention encompasses methods and high-content screening assays designed for producing these therapeutics.
Career Highlights
Throughout his career, Joris De Wit has worked at notable institutions including Vib Vzw and Katholieke Universiteit Leuven (KU Leuven R&D), where his research has substantially contributed to the understanding of therapeutics in brain disorders. His inventive capabilities have been recognized through his patent, showcasing his dedication to advancing medical science.
Collaborations
De Wit's collaborations with esteemed colleagues such as Heather Rice and Bart De Strooper have fostered a rich environment for innovation and research. These partnerships have enhanced his work and broadened the impact of his contributions to the field.
Conclusion
Joris De Wit stands out as a pivotal figure in the realm of neurological and psychiatric disorder therapies. His innovative patent reflects a significant advancement in medical science, underscoring the importance of his work at the intersection of neuroscience and therapeutic development. As research continues to evolve, De Wit’s contributions will likely play a crucial role in shaping future treatments and improving patient outcomes.